| Rule |
|---|
|
Rule 4778-1-01 | Definitions.
For purposes of Chapter 4778. of the Revised Code and the rules promulgated thereunder, the following definitions apply: (A) "Board" means the state medical board of Ohio. (B) "Rare disease" means any disease affecting approximately one in one thousand five hundred people. Supplemental Information |
|
Rule 4778-1-02 | Application for a license.
(A) An applicant for an initial license or initial license designated as a supervised practice license as a genetic counselor shall submit an application under oath in the matter prescribed by the board and provide such other facts and materials as the board requires. (B) No application shall be considered filed, and shall not be reviewed, until the non-refundable application fee provided for in division (A) of section 4778.03 of the Revised Code has been received by the board. (C) All application materials submitted to the board by applicants may be thoroughly investigated. The board may contact individuals, agencies, or organizations for recommendations or other information about applicants as the board deems necessary. Applicants may be requested to appear before the board or a representative thereof as part of the application process. (D) An application for an initial license shall be considered to be complete when all of the following requirements are met: (1) The application fee provided in section 4778.03 of the Revised Code and all documentation required to demonstrate compliance with division (B) of section 4778.03 of the Revised Code has been received by the board; (2) The applicant has complied with the requirements of paragraph (A) of rule 4778-2-02 of the Administrative Code and the board has received the results of the criminal records checks; (3) The board is not conducting an investigation, under section 4778.18 of the Revised Code, of evidence appearing to show that the applicant has violated section 4778.14 of the Revised Code or applicable rules adopted by the board. (E) An application for an initial license designated as a supervised practice license shall be considered to be complete when all of the following requirements are met: (1) The applicant has complied with the requirements of paragraph (D) of this rule, except that the applicant is not required to demonstrate certification as a genetic counselor; (2) The board has received documentation that the applicant is in active candidate status with the American board of genetic counseling. (F) If an applicant fails to complete the application process within six months of initial application filing, the board may notify the applicant in writing of its intention to consider the application abandoned. If no response to that notice is received by the board within thirty days, the board shall consider the application as abandoned and no further processing shall be undertaken with respect to that application. Supplemental Information |
|
Rule 4778-1-03 | Special activity license.
(A) "Current unrestricted license," as that phrase is used in section 4778.09 of the Revised Code and this rule, means a license or other authority to practice that was issued by the appropriate entity or governmental body of another state or territory which lawfully permits the applicant to practice as a genetic counselor without governmental restrictions or limitations. (B) The secretary of the board or, in his or her absence, another member of the board designated by the board, shall determine whether an applicant for a special activity license meets the requirements of section 4778.09 of the Revised Code. In making the determination, the secretary of the board or board designee shall take into consideration all of the following: (1) Whether the practice in this state by the applicant will be associated with a rare disease; (2) The existence of any information warranting investigation prior to issuance of the special activity license; (3) Any available information regarding prior performance by the applicant while practicing in this state. Last updated March 6, 2024 at 1:06 PM Supplemental Information |
|
Rule 4778-1-05 | Collaboration agreement.
(A) The collaboration agreement provided for in division (B) of section 4778.11 of the Revised Code shall meet all of the following criteria: (1) The agreement shall be a written statement identifying and signed by the collaborating physician and genetic counselor who are party to the agreement. (2) The agreement shall contain a general statement of the procedures, decision criteria, or categories of care that a genetic counselor is to follow when ordering genetic tests or other evaluations. (3) The agreement shall provide for a selection of the most appropriate, accurate, and cost-effective methods of diagnosis. (B) A collaborative agreement must be reevaluated at least every two years. If any modification to the agreement is made, the agreement must be re-executed as provided in paragraph (A)(1) of this rule. (C) A signed copy of the collaborative agreement must be maintained by all parties and available for inspection by the board upon request. Supplemental Information |
|
Rule 4778-1-06 | Miscellaneous provisions.
For purposes of Chapter 4778. of the Revised Code and rules promulgated thereunder, the provisions of Chapters 4731-13, 4731-16, 4731-26, 4731-28, 4731-37 and rule 4731-38-02 of the Administrative Code are applicable to the holder of a license to practice as a genetic counselor issued under Chapter 4778. of the Revised Code, as though fully set forth in Chapter 4778-1 or Chapter 4778-2 of the Administrative Code. Last updated November 30, 2023 at 8:26 AM Supplemental Information |